Updated 06:11 GMT, 17 Nov 2026 SPX 7,416.59 -1.92% NDX 27,197.15 -2.67% VIX 22.91 +18.70% GOLD 3,883.00 +0.78% CL 84.99 -0.85% BTC 64,683.65 -0.95%
NAS100 27,197 −2.67% S&P 7,417 −1.92% GOLD $3,883 +0.78% BTC $64,684 −0.95% VIX 22.91 +18.70% latest tape · as of 06:11 UTC
The Screen · Financials

Alpha Bank S.A. logoAlpha Bank S.A.

ALBKY · PNK · USD · Market cap $11.6B

FAIL · Does not pass the screen
1.30 USD

Price as of 13 Nov 2026Daily close, not a live quoteLast reviewed 4 days ago

Screened 2026-11-13 · the tape above runs as of 06:11 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed

Key facts today

  • Price1.30 USD at the 13 Nov 2026 close
  • Fair valueUnder review: our model has no usable estimate for it yet.
  • Our regime readAccumulation, as of 15 Nov 2026
  • Ethical screenDoes not pass
  • Last reviewed13 Nov 2026 (4 days ago)
  • Release timesRelease and earnings times on your chart: Event Guard Mentor

A summary of the dated readings below, not a live quote and not advice.

PRICE · ONE YEAR

Our fair-value range: range not available (screen dated 2026-11-13).

Current read
Accumulation ?
Screened · screened 2026-11-13
  • Trend Accumulation
  • Insiders no filings inside 60 days, left as found
  • Positioning no disclosures inside 60 days, left as found
  • Options no verdict drawn today, left as found
  • Ethical does not pass the values gate
Price1.30 USD
Fair valueUnder review
Our investment reviews on this name
2026-11-12Read Accumulation1.29+0.8% to today ✓Markdown gives way to Accumulation
2026-10-11Read Markdown1.33-2.3% to today ✓Accumulation gives way to Markdown after a 10% rise in 7 weeks
2026-08-21Read Accumulation1.21+7.4% to today ✓Markdown gives way to Accumulation after an 11% rise in 7 weeks
2026-07-02Read Markdown1.09+19.3% to today First review on file: Markdown

Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.

The full research record, in depth, below
The Label · The Season, Not the Day

This name holds its accumulation label.

Alpha Bank S.A. holds its Accumulation at $1.30. The statistical read favours the buyers, held for 7 days.

As held on the ledger · 2026-11-13
PhaseAccumulation
Quantitative stateThe statistical read favours the buyers, held for 7 days
Price at the screen$1.30
Valuation10.75 trailing · N/A forward price to earnings
Values screenFAIL
Beta0.83
The Workings

Five Screens, Shown in Full

Does not pass. Business activity

TestFigureLimitWhat it meansStatus
Business activity Excluded Core business clean Financial sector: banks Fail
Debt load 0.00% Below 33% Interest-bearing debt is just 0.0% of its assets, well under the one-third ceiling: it does not run on borrowed money. Pass
Interest-bearing cash 0.00% Below 33% Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit. Pass
Receivables 0.00% Below 49% Money owed to the company is 0.0% of assets, under the 49% limit. Pass
Revenue purity 183.83% Below 5% 183.8% of revenue comes from non-compliant sources, over the 5% line. Fail

Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.

The Ethical Read

Why It Falls Short, in Plain English

Alpha Bank does not clear the screen at the business-activity stage. It operates in conventional financial services, which the screen treats as interest-based, so the financial ratios are not the deciding factor here.

Read as at 2026-11-15. It updates when the underlying figures move, and past reads are kept below.

Follow this verdict

Get an email when ALBKY's ethical verdict changes

Today ALBKY does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.

Free, no account needed. Every email has a link to stop.

What the Numbers Say It Is Worth

The Fair Value Range

Fair value under review. Our model has no usable estimate for it yet. We show no fair value, margin of safety or value read built on it until the review clears.

How a fair value is estimated: discounted cash flow (DCF).

Price History & Projections

Where our models see it going: no fair-value estimate yet, range not available, dated to the 2026-11-13 screen.

Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.

The Business, in Plain Words
The fundamentals · plain-English read
Trailing P/E10.8xreasonably valued
EPS, trailing0.12
Revenue growth+22.8%strong top-line growth
Profit margin47.0%highly profitable on every dollar of sales
Return on equity11.0%a modest return on shareholder capital
Dividend yield2.23%
Beta0.83steadier than the market
52-week range0.73 - 1.37
Market cap$11.6B

Another profit measure, before interest, tax and non-cash costs: EBITDA.

The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.

Plain-English interpretation of our own screen data. Analysis, not advice.

Where & How to Trade

ALBKY trades on PNK. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.

The Dated Journal · Newest First, Never Edited

Every Entry, As Written

2026-11-12 Accumulation · changed $1.29 -1.5% Entry 12

The framework has shifted from markdown to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 1.5% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 11% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 32%. Our forward projection puts the odds of a 10% gain over the next month near 38%.

2026-11-05 Markdown $1.31 +14.9% Entry 11

The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 14.9% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 6% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 32%. Our forward projection puts the odds of a 10% gain over the next month near 38%.

2026-10-25 Markdown $1.14 -14.3% Entry 10

The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 14.3% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 7% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 32%. Our forward projection puts the odds of a 10% gain over the next month near 38%.

2026-10-11 Markdown · changed $1.33 +0.0% Entry 9

The framework has shifted from accumulation to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 10% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 32%. Our forward projection puts the odds of a 10% gain over the next month near 38%.

2026-10-02 Accumulation $1.33 +4.7% Entry 8

Our analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 4.7% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 10% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 32%. Our forward projection puts the odds of a 10% gain over the next month near 38%.

2026-09-21 Accumulation $1.27 +5.0% Entry 7

Our analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 5.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 10% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 32%. Our forward projection puts the odds of a 10% gain over the next month near 38%.

2026-08-21 Accumulation · changed $1.21 +10.0% Entry 6

The framework has shifted from markdown to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 10.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 10% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 32%. Our forward projection puts the odds of a 10% gain over the next month near 38%.

2026-07-21 Markdown $1.10 +0.9% Entry 5

Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 0.9% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 10% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 32%. Our forward projection puts the odds of a 10% gain over the next month near 38%.

2026-07-18 Markdown $1.09 +0.0% Entry 4

Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 10% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 32%. Our forward projection puts the odds of a 10% gain over the next month near 38%.

2026-07-17 Markdown $1.09 +0.0% Entry 3

Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 10% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 32%. Our forward projection puts the odds of a 10% gain over the next month near 38%.

Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.

Latest News · What the Market Is Reading on ALBKY

Headlines from third-party outlets, linked for reference: not our reporting, not advice.

Related Securities · Others in ALBKY's Space

Screened names in the same industry · explore each on its own page.

What Holding Actually Paid · Price Plus Dividends
If $1,000 had been placed · historical, not a promise
PeriodPrice thenPrice returnDivs per share$1,000 becameTotal return
1 month $1.05 +1.9% · $1,019 +1.9%
2 months $1.04 +2.9% · $1,029 +2.9%
3 months $0.99 +8.1% · $1,081 +8.1%
6 months $0.92 +16.3% · $1,163 +16.3%
1 year $0.81 +32.1% · $1,321 +32.1%
2 years $0.41 +159.0% $0.01 $2,607 +160.7%
3 years $0.36 +194.0% $0.01 $2,959 +195.9%
5 years $0.33 +221.2% $0.01 $3,236 +223.6%

Historical returns from market close data. Past performance does not guarantee future results.

The Ledger's Promise

This entry now belongs to the ledger. Whatever ALBKY does next, these words stay.

Alpha Bank S.A. · ALBKY · Accumulation · $1.30
Recorded 2026-11-13 · before the outcome · scored mechanically

Membership

Thirteen thousand names carry this page. One desk keeps them honest.

Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.

Join the desk

Screening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.

Get our weekly market brief free.